Hepatology

Gilbert syndrome in liver donors appears safe, with no impact on transplant outcomes or survival, according to a systematic review and meta-analysis.

Paediatric autoimmune liver disease shows high survival but limited complete biochemical control after one year of standard therapy in European registry data.

England reports progress towards hepatitis C elimination as prevalence falls, with diagnosis gaps and harm reduction challenges remaining.

Hepatitis E infection affected 3.5% of transplant patients, with high chronicity in those infected and treatment and screening key to care.

Global efforts to tackle viral hepatitis are insufficient, leaving millions at risk and far from 2030 elimination goals.

Paediatric autoimmune hepatitis incidence in Denmark has surged, yet most children maintain liver function with standard immunosuppressive therapy.

Underreported alcohol use masks alcohol-related liver disease, increasing misclassification and obscuring true mortality rates.

Telemedicine nutrition care reduces MASLD and liver disease risk in adults with type 2 diabetes and obesity, showing promise for lifestyle-first interventions.